Diet and the colonic exfoliome: a novel, non-invasive approach to testing interventions in humans
饮食和结肠脱落组:一种测试人类干预措施的新型非侵入性方法
基本信息
- 批准号:10603601
- 负责人:
- 金额:$ 19.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
Diet is an important risk factor for colorectal cancer (CRC) and several dietary constituents implicated in
CRC are modified by gut microbial metabolism. Microbial fermentation of dietary fiber produces short chain
fatty acids, e.g., acetate, propionate, and butyrate. Dietary fiber has been shown to reduce colon tumors in
animal models and, in vitro, butyrate influences cellular pathways important to cancer risk. Further, work from
our group suggests that the combined effects of butyrate and omega-3 polyunsaturated fatty acids (n-3 PUFA)
may enhance the chemopreventive potential of these dietary constituents. We postulate that the relatively low
intakes of n-3 PUFA and fiber in Western populations and the failure to address interactions between these
dietary components may explain why chemoprotective effects of n-3 PUFA and fermentable fibers have not
been detected consistently in prospective cohort studies. We hypothesize that the combined effects of long-
chain n-3 PUFA supplementation and supplemental highly fermentable fiber will alter critical pathways
important to CRC prevention, particularly intrinsic mitochondrial-mediated programmed cell death resulting
from the accumulation of lipid reactive oxygen species (ferroptosis), cell proliferation, and the
eicosanoid/inflammation pathways.
We propose a randomized, controlled crossover pilot study in 30 healthy men and women (50-75 y) to
compare supplemental soluble fiber (35 g/d) + supplemental n-3 PUFA (6 g/d EPA+DHA), in quantities
mirroring mean daily intakes associated with lower CRC risk, with a maltodextrin and corn oil control. Stool
samples will be collected at the beginning, middle (day 15), and end of each of the two 30-day intervention
periods. Using a novel, cost-effective, non-invasive approach, we will evaluate differences in global gene
expression signatures in the stool exfoliome (i.e., sloughed colonic epithelial cells in stool) using RNA-Seq.
We will focus on pathways related to colonic cell proliferation and apoptosis/ferroptosis, cell phenotype, and
inflammatory response. Further, we will evaluate changes in gut microbial functional genes involved in butyrate
production using droplet digital PCR (ddPCR). The collection of multiple samples over the intervention periods
will provide a critical measure of longitudinal changes in response to the supplemental n-3 PUFA and
fermentable fiber.
This proposed pilot human mechanistic study will be the first in humans to integrate and characterize the
relationships between n-3 PUFA and fermentable fiber exposure that modulate programmed cell death and
other CRC-related cell-signaling pathways through metabolic activities of the gut microbiome. Results of this
controlled intervention will help to translate the current mechanistic knowledge from preclinical animal models
to humans and to de-risk and inform approaches for CRC prevention. Interrogating the stool exfoliome is a
novel, cost-effective, non-invasive approach to studying effects of interventions on the human gut.
项目总结
饮食是结直肠癌(CRC)的重要危险因素,几种饮食成分与
结直肠癌是通过肠道微生物代谢进行修饰的。微生物发酵膳食纤维产生短链
脂肪酸,例如,醋酸盐、丙酸和丁酸。膳食纤维已被证明可以减少结肠癌
在动物模型和体外实验中,丁酸盐影响对癌症风险至关重要的细胞通路。更进一步,从
我们的小组认为丁酸和omega-3多不饱和脂肪酸(n-3PUFA)的联合作用
可能会增强这些饮食成分的化学预防潜力。我们假设相对较低的
西方人群中n-3多不饱和脂肪酸和纤维的摄入量以及它们之间的相互作用
饮食成分可以解释为什么n-3多不饱和脂肪酸和可发酵纤维的化学保护作用没有
在前瞻性队列研究中一直被检测到。我们假设,长期的-
补充链n-3多不饱和脂肪酸和补充高度可发酵的纤维将改变关键途径
对预防结直肠癌很重要,特别是由线粒体介导的细胞程序性死亡
由于脂质活性氧的积累(铁下垂),细胞增殖,以及
二十烷类/炎症途径。
我们建议在30名健康男性和女性(50-75岁)中进行随机、对照交叉试验研究,以
比较补充可溶性纤维(35 g/d)+补充n-3多不饱和脂肪酸(6 g/d EPA+DHA)的数量
镜像意味着每天的摄入量与较低的CRC风险相关,麦芽糊精和玉米油控制。大便
样本将在两次为期30天的干预的开始、中期(第15天)和结束时收集
句号。使用一种新的、经济有效的、非侵入性的方法,我们将评估全球基因的差异。
利用RNA-Seq技术在大便脱落层(即大便中脱落的结肠上皮细胞)中的表达特征。
我们将集中在与结肠细胞增殖和凋亡/铁性下垂、细胞表型和
炎症反应。此外,我们将评估与丁酸盐有关的肠道微生物功能基因的变化。
采用液滴数字聚合酶链式反应(DdPCR)进行扩增。在干预期间收集多个样本
将提供应对补充n-3多不饱和脂肪酸的纵向变化的关键衡量标准,并
可发酵纤维。
这项拟议的试验性人类机械学研究将是第一个在人类中整合和表征
N-3多不饱和脂肪酸与可发酵纤维暴露的关系
其他与结直肠癌相关的细胞信号通路通过肠道微生物组的代谢活动。这样做的结果是
受控干预将有助于将当前的机制知识从临床前动物模型转化为
对人类和消除风险,并告知预防儿童权利公约的方法。审问大便脱落是一种
研究干预措施对人体肠道影响的新的、经济有效的、非侵入性的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Stephen Chapkin其他文献
Robert Stephen Chapkin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Stephen Chapkin', 18)}}的其他基金
Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
早产儿肠道成熟和喂养耐受性的营养和临床预测因素
- 批准号:
10717469 - 财政年份:2023
- 资助金额:
$ 19.05万 - 项目类别:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
靶向质膜空间动力学抑制异常的 Wnt 信号传导
- 批准号:
10047029 - 财政年份:2020
- 资助金额:
$ 19.05万 - 项目类别:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
靶向质膜空间动力学抑制异常的 Wnt 信号传导
- 批准号:
10401939 - 财政年份:2020
- 资助金额:
$ 19.05万 - 项目类别:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
靶向质膜空间动力学抑制异常的 Wnt 信号传导
- 批准号:
10630909 - 财政年份:2020
- 资助金额:
$ 19.05万 - 项目类别:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
靶向质膜空间动力学抑制异常的 Wnt 信号传导
- 批准号:
10252842 - 财政年份:2020
- 资助金额:
$ 19.05万 - 项目类别:
Dietary Flavonoids-Microbiota-Ah Receptor Interactions in the Gut
肠道中膳食黄酮类化合物-微生物群-Ah 受体的相互作用
- 批准号:
9791345 - 财政年份:2018
- 资助金额:
$ 19.05万 - 项目类别:
Dietary Flavonoids-Microbiota-Ah Receptor Interactions in the Gut
肠道中膳食黄酮类化合物-微生物群-Ah 受体的相互作用
- 批准号:
10247052 - 财政年份:2018
- 资助金额:
$ 19.05万 - 项目类别:
Dietary and microbial predictors of childhood obesity risk
儿童肥胖风险的饮食和微生物预测因素
- 批准号:
9892995 - 财政年份:2017
- 资助金额:
$ 19.05万 - 项目类别:
Role of Aryl Hydrocarbon Receptor in Microbiota-Colon Stem Cell Interactions
芳基烃受体在微生物群-结肠干细胞相互作用中的作用
- 批准号:
9102325 - 财政年份:2016
- 资助金额:
$ 19.05万 - 项目类别:
相似国自然基金
姜黄素与TRAIL的协同抗肿瘤机制研究
- 批准号:31101223
- 批准年份:2011
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of the initial prototype of a pill sensor to detect colonic polyps and early bowel cancer
开发用于检测结肠息肉和早期肠癌的药丸传感器的初始原型
- 批准号:
MR/Y503411/1 - 财政年份:2024
- 资助金额:
$ 19.05万 - 项目类别:
Research Grant
Understanding the interplay between Shp-2 and microbiota in colonic inflammation
了解 Shp-2 和微生物群在结肠炎症中的相互作用
- 批准号:
478685 - 财政年份:2023
- 资助金额:
$ 19.05万 - 项目类别:
Operating Grants
Colonic mucus-derived sugars fuel the growth and virulence of pathogenic enteric bacteria.
结肠粘液衍生的糖促进致病性肠道细菌的生长和毒力。
- 批准号:
478324 - 财政年份:2023
- 资助金额:
$ 19.05万 - 项目类别:
Operating Grants
Improved Treatment of Colorectal Cancer with CF10
CF10 改善结直肠癌治疗
- 批准号:
10698394 - 财政年份:2023
- 资助金额:
$ 19.05万 - 项目类别:
Defining the Role of Enteric Nervous System Dysfunction in Gastrointestinal Motor and Sensory Abnormalities in Down Syndrome
确定肠神经系统功能障碍在唐氏综合症胃肠运动和感觉异常中的作用
- 批准号:
10655819 - 财政年份:2023
- 资助金额:
$ 19.05万 - 项目类别:
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 19.05万 - 项目类别:
Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation
结直肠肿瘤转化中宿主和微环境的综合单细胞图谱
- 批准号:
10820067 - 财政年份:2023
- 资助金额:
$ 19.05万 - 项目类别:
Define the role of REV-ERB in colonic RORgt+ regulatory T cells
定义 REV-ERB 在结肠 RORgt 调节性 T 细胞中的作用
- 批准号:
10753360 - 财政年份:2023
- 资助金额:
$ 19.05万 - 项目类别: